OBJECTIVES: To examine relationships between eight markers of inflammation (interleukin (IL)-6, IL-6 receptor (R), C-reactive protein (CRP), tumor necrosis factor (TNF)-alpha, TNF receptor 1 (R1), TNFR2, IL-1 receptor antagonist, IL-18) and incident loss of ability to walk 400 m. DESIGN: Prospective cohort study. SETTING: Older adults enrolled in the Invecchiare in Chianti Study. PARTICIPANTS: Community-dwelling participants aged 65 and older (N = 1,006). MEASUREMENTS: The eight inflammatory markers were measured at baseline, and an inflammation score was calculated based on the number of inflammatory markers for which the participant was in the highest quartile. Incidence of mobility disability was determined in participants able to walk 400 m at baseline. Logistic regression models were used to determine whether each of the inflammatory markers and the inflammation score predicted loss of the ability to walk 400 m at 6-year follow-up. RESULTS: After adjusting for covariates, individuals with a TNFR1 level in each of the highest three quartiles (Q2, 3, 4) were more likely to be unable to walk 400 m at follow-up than those with TNFR1 levels in Q1. When adjusting for the same covariates, participants with an inflammation score of 3 or 4 were more likely to become unable to walk 400 m at follow-up than participants with a score of 0. CONCLUSION: These results provide additional evidence that inflammation is a factor in the mechanisms that cause incident mobility disability and suggest that a combined measure of inflammatory markers may improve prediction of functional prognosis.
OBJECTIVES: To examine relationships between eight markers of inflammation (interleukin (IL)-6, IL-6 receptor (R), C-reactive protein (CRP), tumor necrosis factor (TNF)-alpha, TNF receptor 1 (R1), TNFR2, IL-1 receptor antagonist, IL-18) and incident loss of ability to walk 400 m. DESIGN: Prospective cohort study. SETTING: Older adults enrolled in the Invecchiare in Chianti Study. PARTICIPANTS: Community-dwelling participants aged 65 and older (N = 1,006). MEASUREMENTS: The eight inflammatory markers were measured at baseline, and an inflammation score was calculated based on the number of inflammatory markers for which the participant was in the highest quartile. Incidence of mobility disability was determined in participants able to walk 400 m at baseline. Logistic regression models were used to determine whether each of the inflammatory markers and the inflammation score predicted loss of the ability to walk 400 m at 6-year follow-up. RESULTS: After adjusting for covariates, individuals with a TNFR1 level in each of the highest three quartiles (Q2, 3, 4) were more likely to be unable to walk 400 m at follow-up than those with TNFR1 levels in Q1. When adjusting for the same covariates, participants with an inflammation score of 3 or 4 were more likely to become unable to walk 400 m at follow-up than participants with a score of 0. CONCLUSION: These results provide additional evidence that inflammation is a factor in the mechanisms that cause incident mobility disability and suggest that a combined measure of inflammatory markers may improve prediction of functional prognosis.
Authors: David B Reuben; Anna I Cheh; Tamara B Harris; Luigi Ferrucci; John W Rowe; Russell P Tracy; Teresa E Seeman Journal: J Am Geriatr Soc Date: 2002-04 Impact factor: 5.562
Authors: L Ferrucci; S Bandinelli; E Benvenuti; A Di Iorio; C Macchi; T B Harris; J M Guralnik Journal: J Am Geriatr Soc Date: 2000-12 Impact factor: 5.562
Authors: Sarinnapha Vasunilashorn; Antonia K Coppin; Kushang V Patel; Fulvio Lauretani; Luigi Ferrucci; Stefania Bandinelli; Jack M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-31 Impact factor: 6.053
Authors: Ronenn Roubenoff; Helen Parise; Hélène A Payette; Leslie W Abad; Ralph D'Agostino; Paul F Jacques; Peter W F Wilson; Charles A Dinarello; Tamara B Harris Journal: Am J Med Date: 2003-10-15 Impact factor: 4.965
Authors: Fang-Chi Hsu; Stephen B Kritchevsky; Yongmei Liu; Alka Kanaya; Anne B Newman; Sara E Perry; Marjolein Visser; Macro Pahor; Tamara B Harris; Barbara J Nicklas Journal: J Gerontol A Biol Sci Med Sci Date: 2009-02-19 Impact factor: 6.053
Authors: Tina E Brinkley; Xiaoyan Leng; Michael E Miller; Dalane W Kitzman; Marco Pahor; Michael J Berry; Anthony P Marsh; Stephen B Kritchevsky; Barbara J Nicklas Journal: J Gerontol A Biol Sci Med Sci Date: 2009-02-04 Impact factor: 6.053
Authors: Sarinnapha M Vasunilashorn; Long Ngo; Sharon K Inouye; Towia A Libermann; Richard N Jones; David C Alsop; Jamey Guess; Sandra Jastrzebski; Janet E McElhaney; George A Kuchel; Edward R Marcantonio Journal: J Gerontol A Biol Sci Med Sci Date: 2015-07-27 Impact factor: 6.053
Authors: Martine Extermann; Christiaan Leeuwenburgh; Laila Samiian; Marina Sehovic; Jinze Xu; Christopher Cubitt; Paul B Jacobsen; Marco Pahor; Stephen R Grobmyer; Todd M Manini Journal: J Geriatr Oncol Date: 2016-10-13 Impact factor: 3.599
Authors: Mandip S Dhamoon; Ying-Kuen Cheung; Yeseon P Moon; Clinton B Wright; Joshua Z Willey; Ralph L Sacco; Mitchell S V Elkind Journal: Am J Epidemiol Date: 2017-07-01 Impact factor: 4.897
Authors: Christine K Liu; Janet Seo; Dayeun Lee; Kristen Wright; Manjula Kurella Tamura; Jennifer A Moye; Jonathan F Bean; Daniel E Weiner Journal: Am J Kidney Dis Date: 2021-08-20 Impact factor: 8.860
Authors: David Martinez-Gomez; Stefania Bandinelli; Vieri Del-Panta; Eleonora Talluri; Jack M Guralnik; Luigi Ferrucci Journal: Am J Phys Med Rehabil Date: 2018-03 Impact factor: 2.159
Authors: Annie Li; Mai Thanh Tu; Ana Carolina Sousa; Beatriz Alvarado; Georges Karna Kone; Jack Guralnik; Maria Victoria Zunzunegui Journal: BMC Geriatr Date: 2015-08-19 Impact factor: 3.921
Authors: Parvin Kumar; Miranda Stiernborg; Anna Fogdell-Hahn; Kristoffer Månsson; Tomas Furmark; Daniel Berglind; Philippe A Melas; Yvonne Forsell; Catharina Lavebratt Journal: PLoS One Date: 2022-02-03 Impact factor: 3.240